Knee Osteoarthritis and Rehabilitation
Launched by KARABUK UNIVERSITY · May 22, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of laser treatment combined with traditional physiotherapy for patients who have knee osteoarthritis (OA). Osteoarthritis is a common condition that causes pain and stiffness in the knee, especially during activities or after sitting for a long time. The goal of the study is to see if adding laser treatment can improve pain relief, movement, muscle strength, and balance for those who have previously received a specific type of injection called PRP (platelet-rich plasma).
To participate in this trial, individuals must be between 18 and 65 years old and have been diagnosed with knee OA by a doctor. They should have received a PRP injection and have OA that affects only one knee, classified as stage I to III on a specific scale used by doctors. However, those with more severe OA (stage IV), a high body weight (BMI over 40), or certain neurological conditions cannot take part in the study. Participants can expect to receive treatment and assessments to help improve their knee function and overall well-being.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Volunteering to participate in the study
- • Being diagnosed with knee OA by a specialist physician
- • Having had PRP injection applied by a specialist physician
- • Having unilateral knee OA
- • Being stage I-stage III in the Kellgren-Lawrence OA classification
- • Being between the ages of 18-65
- Exclusion Criteria:
- • Being stage IV in the Kellgren-Lawrence OA classification
- • BMI being more than 40 kg/m2
- • Patients who do not cooperate well
- • Patients with neurological or neuromuscular disease
About Karabuk University
Karabuk University is a distinguished educational institution located in Turkey, dedicated to advancing scientific research and innovation across various fields, including healthcare. As a clinical trial sponsor, the university plays a pivotal role in facilitating cutting-edge research aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a commitment to ethical standards and rigorous scientific methodology, Karabuk University collaborates with healthcare professionals and researchers to design and implement clinical trials that address pressing health challenges, ultimately striving to enhance treatment options and promote public health initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karabük, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported